{"text": ["Novartis", "Gets", "EC", "Approval", "for", "Enerzair", "Breezhaler", "for", "Asthma"], "created_at": "2020-07-07 14:25:02"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Novartis,", "Equinix,", "Newmont,", "Enterprise", "Products", "Partners", "and", "Franco-Nevada"], "created_at": "2020-07-07 13:52:01"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Novavax", "Lands", "$1.6B", "For", "COVID-19", "Vaccine,", "Amgen", "Prevails", "In", "Avastin", "Biosimilar", "Lawsuit,", "Cellectis", "Study", "Placed", "On", "Clinical", "Hold"], "created_at": "2020-07-07 12:17:27"}
{"text": ["Yates", "Class", "Action", "Law", "Encourages", "Long", "Term", "Stockholders", "of", "Novartis", "AG", "(NYSE:", "NVS)", "to", "Contact", "The", "Firm"], "created_at": "2020-07-07 11:58:00"}
